Rates of adverse events of grade @ or @ were similar in the two groups ( hazard ratio , @ ; @ % CI , @ to @ ; P = @ ) , but more grade @ adverse events occurred in the prophylaxis-stopped group ( hazard ratio , @ ; @ % CI , @ to @ ; P = @ ) , with anemia accounting for the largest number of events ( @ , vs. @ with continued prophylaxis ) .